Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susan O'Brien

Showing results (71-80 of 643) with videos related to

Pageof 65
Sort By:
Hematology/Oncology Clinics of North America|October 15, 2009
Monoclonal antibody therapy with rituximab for acute lymphoblastic leukemiaDeborah A Thomas, Susan O'Brien, Hagop M Kantarjian
Frontiers in Bioscience (Elite Edition)|January 7, 2014
Inotuzumab ozogamicin in the treatment of acute lymphoblastic leukemiaNitin Jain, Susan O'Brien, Deborah Thomas, et al.
Cancer|April 21, 2015
New insights into the pathophysiology and therapy of adult acute lymphoblastic leukemiaElias Jabbour, Susan O'Brien, Marina Konopleva, et al.
Blood|May 23, 2015
Monoclonal antibodies in acute lymphoblastic leukemiaElias Jabbour, Susan O'Brien, Farhad Ravandi, et al.
Clinical Advances in Hematology & Oncology : H&O|December 5, 2006
Chronic lymphocytic leukemia: current and emerging treatment approachesNeil E Kay, Kanti R Rai, Susan O'Brien
The New England Journal of Medicine|September 27, 2013
Ibrutinib in relapsed chronic lymphocytic leukemiaJohn C Byrd, Susan O'Brien, Danelle F James
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 15, 2012
Monoclonal antibody-based therapies: a new dawn in the treatment of acute lymphoblastic leukemiaHagop Kantarjian, Deborah Thomas, Alan S Wayne, et al.
Current Hematologic Malignancy Reports|April 29, 2010
New approaches to the management of Philadelphia-chromosome-positive acute lymphocytic leukemiaDeborah A Thomas, Susan O'Brien, Jorge Cortes, et al.
Journal of Blood Medicine|January 28, 2012
Critical appraisal of the role of rituximab in the treatment of patients with previously untreated or treated chronic lymphocytic leukemia (CLL)Aref Al-Kali, William Wierda, Michael Keating, et al.
Expert Review of Hematology|November 23, 2019
Reassessing the role of chemoimmunotherapy in chronic lymphocytic leukemiaYasir Khan, Yung Lyou, Monica El-Masry, et al.
Pageof 65

Showing results (71-80 of 643) with videos related to

Sort By:
Pageof 65
Hematology/Oncology Clinics of North America|October 15, 2009
Monoclonal antibody therapy with rituximab for acute lymphoblastic leukemiaDeborah A Thomas, Susan O'Brien, Hagop M Kantarjian
Frontiers in Bioscience (Elite Edition)|January 7, 2014
Inotuzumab ozogamicin in the treatment of acute lymphoblastic leukemiaNitin Jain, Susan O'Brien, Deborah Thomas, et al.
Cancer|April 21, 2015
New insights into the pathophysiology and therapy of adult acute lymphoblastic leukemiaElias Jabbour, Susan O'Brien, Marina Konopleva, et al.
Blood|May 23, 2015
Monoclonal antibodies in acute lymphoblastic leukemiaElias Jabbour, Susan O'Brien, Farhad Ravandi, et al.
Clinical Advances in Hematology & Oncology : H&O|December 5, 2006
Chronic lymphocytic leukemia: current and emerging treatment approachesNeil E Kay, Kanti R Rai, Susan O'Brien
The New England Journal of Medicine|September 27, 2013
Ibrutinib in relapsed chronic lymphocytic leukemiaJohn C Byrd, Susan O'Brien, Danelle F James
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 15, 2012
Monoclonal antibody-based therapies: a new dawn in the treatment of acute lymphoblastic leukemiaHagop Kantarjian, Deborah Thomas, Alan S Wayne, et al.
Current Hematologic Malignancy Reports|April 29, 2010
New approaches to the management of Philadelphia-chromosome-positive acute lymphocytic leukemiaDeborah A Thomas, Susan O'Brien, Jorge Cortes, et al.
Journal of Blood Medicine|January 28, 2012
Critical appraisal of the role of rituximab in the treatment of patients with previously untreated or treated chronic lymphocytic leukemia (CLL)Aref Al-Kali, William Wierda, Michael Keating, et al.
Expert Review of Hematology|November 23, 2019
Reassessing the role of chemoimmunotherapy in chronic lymphocytic leukemiaYasir Khan, Yung Lyou, Monica El-Masry, et al.
Pageof 65